Chromatin Regulation / Acetylation
Mono-Methyl Histone H3 (Lys4) Antibody
|
イイネ!(0)
|
|
|
| CSTコード |
包装 |
希望納入価格 (円) |
国内在庫  |
ご登録代理店情報  カスタマー情報にご登録いただいた代理店を表示しています。
ご登録代理店の変更は こちら。 |
| #9723S | 100 μL | 57,000 | |
|
| #9723L | 300 μL | 137,000 | |
Histone H3抗体製品一覧
9723 の推奨プロトコール
最適な結果を得るために:Cell Signaling Technology (CST) 社は、各製品の推奨プロトコールを使用することを強くお薦めいたします。
推奨プロトコールはCST社内試験の徹底的なバリデーションに基づいて作成されておりますので、正確かつ再現性の高い結果が得られます。
注:各製品に最適化されたプロトコールをリンクしています。
| | |
-
9723:
-
Immunofluorescence
Immunoprecipitation
Western Blotting
| 用途(希釈倍率) | |
| ウェスタンブロッティング(1:1,000)、免疫沈降(1:25)、免疫細胞染色(IF-IC)(1:200) |
| 種交差性 | |
| ヒト、マウス、ラット、サル、(アフリカツメガエル、ゼブラフィッシュ) |
| 特異性・感度 | |
| 内在性レベルのLys4 がモノメチル化されたHistone H3 タンパク質を検出します。また、Lys4 がジメチル化Histone H3 タンパク質とも非常に弱くですが交差します。非メチル化およびトリメチル化されたHistone H3 タンパク質とは交差しません。またLys9、Lys27 およびLys36 がメチル化されたHistone H3 タンパク質およびLys20 がメチル化されたHistone H4 タンパク質とも交差しません。 |
| 使用抗原 | |
| Lys4がモノメチル化されたヒトのHistone H3 のN 末端領域(合成ペプチド) |
| ※括弧付きの動物種は配列が100%相同であるため反応すると推定されます。 |
Western Blotting

Western blot analysis of lysates from HeLa, NIH/3T3, C6 and COS cells, using Mono-Methyl-Histone H3 (Lys4) Antibody.
IF-IC

Confocal immunofluorescent images of NIH/3T3 cells labeled with Mono-Methyl-Histone H3 (Lys4) Antibody (green, left) compared to an isotype control (right). Actin filaments have been labeled with Alexa Fluor® 555 phalloidin (red).
ELISA

Mono-Methyl-Histone H3 (Lys4) Antibody specificity was determined by peptide ELISA. Each graph depicts a titration of this antibody and the corresponding reactivity toward the non-methyl, mono-methyl, di-methyl and tri-methyl states of the indicated histone H3 or H4 lysine residue.
The nucleosome, made up of four core histone proteins (H2A, H2B, H3, and H4), is the primary building block of chromatin. Originally thought to function as a static scaffold for DNA packaging, histones have now been shown to be dynamic proteins, undergoing multiple types of post-translational modifications, including acetylation, phosphorylation, methylation, and ubiquitination (1). Histone methylation is a major determinant for the formation of active and inactive regions of the genome and is crucial for the proper programming of the genome during development (2,3). Arginine methylation of histones H3 (Arg2, 17, 26) and H4 (Arg3) promotes transcriptional activation and is mediated by a family of protein arginine methyltransferases (PRMTs), including the co-activators PRMT1 and CARM1 (PRMT4) (4). In contrast, a more diverse set of histone lysine methyltransferases has been identified, all but one of which contain a conserved catalytic SET domain originally identified in the Drosophila Su(var)3-9, Enhancer of zeste, and Trithorax proteins. Lysine methylation occurs primarily on histones H3 (Lys4, 9, 27, 36, 79) and H4 (Lys20) and has been implicated in both transcriptional activation and silencing (4). Methylation of these lysine residues coordinates the recruitment of chromatin modifying enzymes containing methyl-lysine binding modules such as chromodomains (HP1, PRC1), PHD fingers (BPTF, ING2), tudor domains (53BP1), and WD-40 domains (WDR5) (5-8). The discovery of histone demethylases such as PADI4, LSD1, JMJD1, JMJD2, and JHDM1 has shown that methylation is a reversible epigenetic marker (9).
-
Peterson, C.L. and Laniel, M.A. (2004) Curr. Biol. 14, R546-R551.
-
Kubicek, S. et al. (2006) Ernst Schering Res. Found Workshop, 1-27.
-
Lin, W. and Dent, S.Y. (2006) Curr. Opin. Genet. Dev. 16, 137-142.
-
Lee, D.Y. et al. (2005) Endocr. Rev. 26, 147-170.
-
Daniel, J.A. et al. (2005) Cell Cycle 4, 919-926.
-
Shi, X. et al. (2006) Nature 442, 96-99.
-
Wysocka, J. et al. (2006) Nature 442, 86-90.
-
Wysocka, J. et al. (2005) Cell 121, 859-872.
-
Trojer, P. and Reinberg, D. (2006) Cell 125, 213-217.